MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Arzneimittelhersteller |
Börse |
NYSESPB |
Anteile |
181 M |
Marktkapitalisierung |
$ 11.5 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Arzneimittelhersteller"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Solid Biosciences
SLDB
|
$ 9.93 | 1.31 % | $ 869 M | Nasdaq Global Select Market,SPB | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
$ 1.33 | 0.38 % | $ 2.24 M | Nasdaq Capital Market | USA |
 |
TherapeuticsMD
TXMD
|
$ 2.14 | 0.22 % | $ 24.8 M | Nasdaq Global Select Market | USA |
 |
Veru
VERU
|
$ 2.58 | 0.39 % | $ 37.8 M | Nasdaq Capital Market | USA |
 |
Viatris
VTRS
|
$ 16.61 | 0.03 % | $ 19.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
- | 0.86 % | $ 117 M | Nasdaq Capital Market | USA |
 |
Agile Therapeutics
AGRX
|
- | 10.11 % | $ 58.2 M | Nasdaq Capital Market | USA |
 |
Alimera Sciences
ALIM
|
- | - | $ 142 M | Nasdaq Global Market | USA |
 |
DURECT Corporation
DRRX
|
- | - | $ 50.1 M | Nasdaq Capital Market | USA |
 |
Eagle Pharmaceuticals
EGRX
|
- | -39.89 % | $ 27.7 M | Nasdaq Global Market,SPB | USA |
 |
Lannett Company
LCI
|
- | 1.15 % | $ 7.11 M | NYSE | USA |
 |
OptiNose
OPTN
|
- | - | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
PetIQ
PETQ
|
- | 1.64 % | $ 400 M | Nasdaq Global Select Market,SPB | USA |
 |
Radius Health
RDUS
|
- | - | $ 1.42 B | Nasdaq Global Market | USA |
 |
Recro Pharma
REPH
|
- | -4.76 % | $ 65.3 M | Nasdaq Global Select Market | USA |
 |
Emergent BioSolutions
EBS
|
$ 6.0 | 0.08 % | $ 321 M | NYSE,SPB | USA |
 |
Endo International plc
ENDP
|
- | - | $ 28.9 M | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Relmada Therapeutics
RLMD
|
$ 4.25 | 1.37 % | $ 168 M | Nasdaq Global Select Market,SPB | USA |
 |
Bausch Health Companies
BHC
|
$ 6.43 | 0.31 % | $ 2.38 B | NYSE |  Canada |
 |
PLx Pharma
PLXP
|
- | -27.8 % | $ 2.56 M | Nasdaq Capital Market | USA |
 |
HEXO Corp.
HEXO
|
- | 2.45 % | $ 38.1 M | NYSE | Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
- | -0.1 % | $ 2.03 B | Nasdaq Global Select Market |  Schweden |
 |
Athenex
ATNX
|
- | -23.39 % | $ 1.76 M | Nasdaq Global Select Market | USA |
 |
China Pharma Holdings
CPHI
|
$ 0.84 | 2.56 % | $ 3.6 M | NYSE American |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
$ 6.62 | 0.29 % | $ 98.3 M | Nasdaq Global Select Market | USA |
 |
Cronos Group
CRON
|
$ 3.19 | 0.62 % | $ 1.22 B | Nasdaq Global Market | Canada |
 |
Evolus
EOLS
|
$ 8.88 | 2.76 % | $ 572 M | Nasdaq Global Market | USA |
 |
Harrow Health
HROW
|
$ 37.85 | 0.73 % | $ 1.39 B | Nasdaq Global Market | USA |
 |
Sundial Growers
SNDL
|
$ 1.44 | 0.35 % | $ 372 M | Nasdaq Global Select Market | Canada |
 |
Canopy Growth Corporation
CGC
|
$ 0.97 | 1.73 % | $ 289 M | Nasdaq Global Select Market | Canada |
 |
OrganiGram Holdings
OGI
|
$ 1.12 | 0.42 % | $ 107 M | Nasdaq Global Select Market | Canada |
 |
Aurora Cannabis
ACB
|
$ 3.87 | 1.54 % | $ 212 M | NYSE | Canada |
 |
Organogenesis Holdings
ORGO
|
$ 1.6 | 4.27 % | $ 203 M | Nasdaq Capital Market | USA |
 |
Pacira BioSciences
PCRX
|
$ 25.87 | 0.08 % | $ 1.15 B | Nasdaq Global Select Market,SPB | USA |
 |
Perrigo Company plc
PRGO
|
$ 14.58 | 4.56 % | $ 2.02 B | NYSE | USA |
 |
Rockwell Medical
RMTI
|
$ 8.06 | 0.94 % | $ 290 M | Nasdaq Global Market | USA |
 |
Aerie Pharmaceuticals
AERI
|
- | - | $ 754 M | Nasdaq Global Market,SPB | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
- | 7.5 % | $ 6.35 M | Nasdaq Global Market | USA |
 |
Assertio Holdings
ASRT
|
- | - | $ 150 M | Nasdaq Capital Market | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
- | - | $ 2.06 B | Nasdaq Global Select Market |  France |
 |
Evoke Pharma
EVOK
|
- | - | $ 36.6 M | Nasdaq Capital Market | USA |
 |
Jupiter Wellness
JUPW
|
- | - | $ 33.6 M | Nasdaq Global Select Market | USA |
 |
Neoleukin Therapeutics
NLTX
|
- | - | $ 193 M | Nasdaq Global Select Market | Canada |
 |
ProPhase Labs
PRPH
|
- | - | $ 5.07 M | Nasdaq Capital Market | USA |
 |
SCYNEXIS
SCYX
|
$ 5.15 | 0.75 % | $ 257 M | Nasdaq Global Select Market | USA |
 |
Tricida
TCDA
|
- | - | $ 3.25 M | Nasdaq Global Select Market,SPB | USA |
 |
Tilray
TLRY
|
$ 4.3 | 0.22 % | $ 3.83 B | Nasdaq Global Select Market | Canada |
 |
cbdMD
YCBD
|
$ 0.5 | 5.07 % | $ 2.01 M | NYSE American | USA |
 |
Zomedica Corp.
ZOM
|
- | -0.21 % | $ 98 M | NYSE American | USA |